Reactive oxygen species (ROS) such as superoxide (O2-) generated by NAD(P)H oxidases have emerged as important molecules in blood pressure regulation. This study investigated the effect of apocynin and catalase on blood pressure and renal haemodynamic and excretory function in an L-NAME induced hypertension model. Forty Male Wistar-Kyoto (WKY) rats (n=8 per group) were treated with either: vehicle (WKY-C); L-NAME (WKY-L, 15 mg/kg/day in drinking fluid); WKY-L given apocynin to block NAD(P)H oxidase (WKY-LApo, 73 mg/kg/day in drinking water.); WKY-L given catalase to enhance ROS scavenging (WKY-LCat, 10000 U/kg/day i.p.); and WKY-L receiving apocynin plus catalase (WKY-LApoCat) daily for 14 days. L-NAME elevated systolic blood pressure (SBP), 116+/-1 to 181±4 mmHg, reduced creatinine clearance, 1.69+/-0.26 to 0.97+/-0.05 ml/min/kg and fractional sodium excretion, 0.84+/-0.09 to 0.55+/-0.09 % at day 14. Concomitantly, plasma malondialdehyde (MDA) increased six fold, while plasma total superoxide dismutase (T-SOD), plasma nitric oxide (NO) and plasma total antioxidant capacity (T-AOC) were decreased by 60-70 % and Nox 4 mRNA expression was increased 2-fold. Treatment with apocynin and catalase attenuated the increase in SBP and improved renal function, enhanced antioxidative stress capacity and reduced the magnitude of Nox4 mRNAs expression in the L-NAME treated rats. This study demonstrated that apocynin and catalase offset the development of L-NAME induced hypertension, renal dysfunction and reduced oxidative stress status, possibly contributed by a reduction in Nox4 expression during NOS inhibition. These findings would suggest that antioxidant compounds such as apocynin and catalase have potential in treating cardiovascular diseases.

Cardiovascular and Renal Physiology Research Laboratory School of Pharmaceutical Sciences Universiti Sains Malaysia Minden Penang Malaysia or Department of Pharmacology School of Pharmaceutical Sciences Universiti Sains Malaysia Minden Penang Malaysia

Zobrazit více v PubMed

ACTIVIT SRSN. NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. Circ Res. 1992;70:607–611. doi: 10.1161/01.RES.70.3.607. PubMed DOI

ADLER S, HUANG H. Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase. Am J Physiol Renal Physiol. 2004;287:F907–F913. doi: 10.1152/ajprenal.00060.2004. PubMed DOI

AHMAD A, SATTAR MA, AZAM M, KHAN SA, BHATT O, JOHNS EJ. Interaction between nitric oxide and renal alpha1-adrenoreceptors mediated vasoconstriction in rats with left ventricular hypertrophyin Wistar Kyoto rats. PLoS One. 2018;13:e0189386. doi: 10.1371/journal.pone.0189386. PubMed DOI PMC

AHMAD A, SATTAR MA, RATHORE HA, KHAN SA, ABDULLAH NA, JOHNS EJ. Downregulation of cystathionine y lyase and endothelial nitric oxide synthase and reduced responsiveness of Alpha1A adrenergic receptors in the kidneys of left ventricular hypertrophied Wistar Kyoto rats. Turk J Biol. 2016;40:1129–1139. doi: 10.3906/biy-1506-78. DOI

AHMEDA AF, JOHNS EJ. The regulation of blood perfusion in the renal cortex and medulla by reactive oxygen species and nitric oxide in the anaesthetised rat. Acta Physiol. 2012;204:443–450. doi: 10.1111/j.1748-1716.2011.02346.x. PubMed DOI

BERKBAN T, BOONPROM P, BUNBUPHA S, WELBAT J, KUKONGVIRIYAPAN U, KUKONGVIRIYAPAN V, PAKDEECHOTE P, PRACHANEY P. Ellagic acid prevents L-NAME-induced hypertension via restoration of eNOS and p47phox expression in rats. Nutrients. 2015;7:5265–5280. doi: 10.3390/nu7075222. PubMed DOI PMC

BRIONES AM, TABET F, CALLERA GE, MONTEZANO AC, YOGI A, HE Y, QUINN MT, SALAICES M, TOUYZ RM. Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR. Am J Hypertens. 2011;5:137–153. doi: 10.1016/j.jash.2011.02.001. PubMed DOI

BRUNINI TMC, De MOURA RS, MALAGRIS LEN, ROBERTS NB, ELLORY JC, RIBEIRO ACM. Diminished L-arginine bioavailability in hypertension. Clin Sci. 2004;107:391–397. doi: 10.1042/CS20030412. PubMed DOI

CASTRO MC, FRANCINI F, SCHINELLA G, CALDIZ CI, ZUBIRAS MG, GAGLIARDINO JJ, MASSA ML. Apocynin administration prevents the changes induced by a fructose-rich diet on rat liver metabolism and the antioxidant system. Clin Sci. 2012;123:681–692. doi: 10.1042/CS20110665. PubMed DOI

CHAN SHH, TAI MH, LI CY, CHAN JYH. Reduction in molecular synthesis or enzyme activity of superoxide dismutases and catalase contributes to oxidative stress and neurogenic hypertension in spontaneously hypertensive rats. Free Radic Biol Med. 2006;40:2028–2039. doi: 10.1016/j.freeradbiomed.2006.01.032. PubMed DOI

CHIA TY. MSc Research report. Universiti Sains; Malaysia: 2013. Modification of renal haemodynamics in cyclosporine a-induced renal failure rats by Tempol.

CHIA TY, MURUGAIYAH V, SATTAR MA, KHAN K, ABDUL N, AHMAD A, ABDULLA MH, JOHNS EJ, MEI HY, AKHTAR S, AHMAD FU. The restorative effect of apocynin and catalase in L-arginine-induced hypotension on normotensive subjects - the role of oxidative stress. Physiol Res. 2020;69:1051–1066. doi: 10.33549/physiolres.934426. PubMed DOI PMC

CHIA TY, SATTAR MA, ABDULLA MH, RATHORE HA, AHMAD FUD, KAUR G, ABDULLAH NA, JOHNS EJ. The effects of tempol on renal function and hemodynamics in cyclosporine-induced renal insufficiency rats. Ren Fail. 2013;35:978–988. doi: 10.3109/0886022X.2013.809563. PubMed DOI

CHIA TY, SATTAR MA, RATHORE HA, ABDULLAH MH, SINGH GKC, AHMAD FUD, IBRAHEEM ZO, LI KJ, PEI YP, JIN OH, ABDULLAH NA. JONHS EJ: Superoxide dismutase mimetic tempol normalized the blood pressure and renal functions in L-NAME induced hypertension rats: The role of oxidative stress. Int J Pharm Sci Rev Res. 2013;18:61–71.

COSSON E, HERISSE M, LAUDE D, THOMAS F, VALENSI PE, ATTALI JR, SAFAR ME. DABIRE H: Aortic stiffness and pulse pressure amplification in Wistar-Kyoto and spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2007;292:H2506–H2512. doi: 10.1152/ajpheart.00732.2006. PubMed DOI

GEISZT M, KOPP JB, VARNAI P, LETO TL. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A. 2000;97:8010–8014. doi: 10.1073/pnas.130135897. PubMed DOI PMC

GRIENDLING KK, MINIERI CA, OLLERENSHAW JD, ALEXANDER RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141–1148. doi: 10.1161/01.RES.74.6.1141. PubMed DOI

GUZIK TJ, SADOWSKI J, KAPELAK B, JOPEK A, RUDZINSKI P, PILLAI R, KORBUT R, CHANNON KM. Systemic regulation of vascular NAD(P)H oxidase activity and Nox isoform expression in human arteries and veins. Arterioscler Thromb Vasc Biol. 2004;24:1614–1620. doi: 10.1161/01.ATV.0000139011.94634.9d. PubMed DOI

HIRAI T, MUSCH TI, MORGAN DA, KREGEL KC, CLAASSEN DE, PICKAR JG, LEWIS SJ, KENNEY MJ. Differential sympathetic nerve responses to nitric oxide synthase inhibition in anesthetized rats. Am J Physiol Regul Integr Comp Physiol. 1995;269:R807–R813. doi: 10.1152/ajpregu.1995.269.4.R807. PubMed DOI

HOWE PR, ROGERS PF. HEAD GA: Limited baroreflex control of heart rate in young stroke-prone spontaneously hypertensive rats. J Hypertens. 1989;7:69–75. doi: 10.1097/00004872-198901000-00011. PubMed DOI

IBRAHEEM ZO, SATTAR MA, RATHORE HA, ABDULLAH MH, YAM MF. Effect of palm oil leaf extract Eliais guinesis (standardized ethanolic fraction) on progression of experimental nephrotoxicity induced by gentamicin in Sprague Dawley rats. Int J Pharm Sci Res. 2011;9:1–6.

IGNARRO LJ. Nitric oxide: A unique endogenous signaling molecule in vascular biology (Nobel lecture) Angew Chem Int Ed. 1999;38:1882–1892. doi: 10.1002/(SICI)1521-3773(19990712)38:13/14<1882::AID-ANIE1882>3.0.CO;2-V. PubMed DOI

JOHNS EJ, O’SHAUGHNESSY B, O’NEILL S, LANE B, HEALY V. Impact of elevated dietary sodium intake on NAD (P) H oxidase and SOD in the cortex and medulla of the rat kidney. Am J Physiol Regul Integr Comp Physiol. 2010;299:R234–R240. doi: 10.1152/ajpregu.00541.2009. PubMed DOI

JOHNSON DK, SCHILLINGER KJ, KWAIT DM, HUGHES CV, McNAMARA EJ, ISHMAEL F, O’DONNELL RW, CHANG M-M, HOGG MG, DORDICK JS. Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium. 2002;9:191–203. doi: 10.1080/10623320213638. PubMed DOI

KANG DG, SOHN EJ, LEE YM, LEE AS, HAN JH, KIM TY, LEE HS. Effects of bulbus Fritillaria water extract on blood pressure and renal functions in the L-NAME-induced hypertensive rats. J Ethnopharmacol. 2004;91:51–56. doi: 10.1016/j.jep.2003.11.015. PubMed DOI

KITIYAKARA C, CHABRASHVILI T, CHEN Y, BLAU J, KARBER A, ASLAM S, WELCH WJ, WILCOX CS. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol. 2003;14:2775–2782. doi: 10.1097/01.ASN.0000092145.90389.65. PubMed DOI

LASSEGUE B, GRIENDLING KK. NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol. 2010;30:653–661. doi: 10.1161/ATVBAHA.108.181610. PubMed DOI PMC

LASSEGUE B, San MARTIN A, GRIENDLING KK. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res. 2012;110:1364–1390. doi: 10.1161/CIRCRESAHA.111.243972. PubMed DOI PMC

LEE D-Y, WAUQUIER F, EID AA, ROMAN LJ, GHOSH-CHOUDHURY G, KHAZIM K, BLOCK K, GORIN Y. Nox4 NADPH oxidase mediates peroxynitrite-dependent uncoupling of endothelial nitric-oxide synthase and fibronectin expression in response to angiotensin II: Role of mitochondria reactive oxygen species. J Biol Chem. 2013;288:28668–28686. doi: 10.1074/jbc.M113.470971. PubMed DOI PMC

LIVAK KJ, SCHMITTGEN TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-^^CT method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. PubMed DOI

LOOMIS ED, SULLIVAN JC, OSMOND DA, POLLOCK DM, POLLOCK JS. Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta. J Pharmacol Exp Ther. 2005;315:1058–1064. doi: 10.1124/jpet.105.091728. PubMed DOI

MOUNT PF, POWER DA. Nitric oxide in the kidney: functions and regulation of synthesis. Acta Physiol. 2006;187:433–446. doi: 10.1111/j.1748-1716.2006.01582.x. PubMed DOI

NAKAZONO K, WATANABE N, MATSUNO K, SASAKI J, SATO T, INOUE M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A. 1991;88:10045–10048. doi: 10.1073/pnas.88.22.10045. PubMed DOI PMC

NISTALA R, WEI Y, SOWERS JR, WHALEY-CONNELL A. Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney disease. Transl Res. 2009;153:102–113. doi: 10.1016/j.trsl.2008.12.008. PubMed DOI PMC

PECHÁNOVÁ O, DOBEŠOVÁ Z, CEJKA J, KUNEŠ J, ZICHA J. Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase. J Hypertens. 2004;22:167–173. doi: 10.1097/00004872-200401000-00026. PubMed DOI

RUBBO H, TARPEY M, FREEMAN BA. Nitric oxide and reactive oxygen species in vascular injury. Biochem Soc Symp. 1995;61:33–45. doi: 10.1042/bss0610033. PubMed DOI

SAHA SK, OHINATA H, KUROSHIMA A. Effects of acute and chronic inhibition of nitric oxide synthase on brown adipose tissue thermogenesis. Jpn J Physiol. 1996;46:375–382. doi: 10.2170/jjphysiol.46.375. PubMed DOI

SELEMIDIS S, SOBEY CG, WINGLER K, SCHMIDT HHHW, DRUMMOND GR. NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther. 2008;120:254–291. doi: 10.1016/j.pharmthera.2008.08.005. PubMed DOI

SHOKOJI T, NISHIYAMA A, FUJISAWA Y, HITOMI H, KIYOMOTO H, TAKAHASHI N, KIMURA S, KOHNO M, ABE Y. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension. 2003;41:266–273. doi: 10.1161/01.HYP.0000049621.85474.CF. PubMed DOI

STEFANSKA J, PAWLICZAK R. Apocynin: Molecular aptitudes. Mediators Inflamm. 2008;2008:106507. doi: 10.1155/2008/106507. PubMed DOI PMC

TAN YC, ABDUL SATTAR M, AHMEDA AF, ABDUL KARIM KHAN N, MURUGAIYAH V, AHMAD A, HASSAN Z, KAUR G, ABDULLA MH, JOHNS EJ. Apocynin and catalase prevent hypertension and kidney injury in cyclosporine A-induced nephrotoxicity in rats. PLoS One. 2020;15:e0231472. doi: 10.1371/journal.pone.0231472. PubMed DOI PMC

TANIR HM, SENER T, INAL M, AKYUZ F, UZUNER K, SIVRI E. Effect of quercetine and glutathione on the level of superoxide dismutase, catalase, malonyldialdehyde, blood pressure and neonatal outcome in a rat model of pre-eclampsia induced by NG-nitro-L-arginine-methyl ester. Eur J Obstet Gynecol Reprod Biol. 2005;118:190–195. doi: 10.1016/j.ejogrb.2004.04.033. PubMed DOI

TOGASHI H, SAKUMA I, YOSHIOKA M, KOBAYASHI T, YASUDA H, KITABATAKE A, SAITO H, GROSS SS, LEVI R. A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther. 1992;262:343–347. PubMed

TOUYZ RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Sign. 2005;7:1302–1314. doi: 10.1089/ars.2005.7.1302. PubMed DOI

WANG Y-X, HALKS-MILLER M, VERGONA R, SULLIVAN ME, FITCH R, MALLARI C, MARTIN-McNULTY B, Da CUNHA V, FREAY A, RUBANYI GM. Increased aortic stiffness assessed by pulse wave velocity in apolipoprotein E-deficient mice. Am J Physiol Heart Circ Physiol. 2000;278:H428–H434. doi: 10.1152/ajpheart.2000.278.2.H428. PubMed DOI

WHALEY-CONNELL A, JOHNSON MS, SOWERS JR. Aldosterone: role in the cardiometabolic syndrome and resistant hypertension. Prog Cardiovasc Dis. 2010;52:401–409. doi: 10.1016/j.pcad.2009.12.004. PubMed DOI PMC

WILLIAMS HC, GRIENDLING KK. NADPH oxidase inhibitors: new antihypertensive agents? J Cardiovasc Pharmacol. 2007;50:9–16. doi: 10.1097/FJC.0b013e318063e820. PubMed DOI

WORLD HEALTH ORGANIZATION. Causes of death 2008: Data sources and methods. Geneva: 2017. [Accessed 9th May, 2019]. http://www.who.int/healthinfo/global_burden_disease/cod_2008_sources_methods.pdf .

XAVIER F, MAGALHAES AMF, GONTIJO JAR. Effect of inhibition of nitric oxide synthase on blood pressure and renal sodium handling in renal denervated rats. Braz J Med Biol. 2000;33:347–354. doi: 10.1590/S0100-879X2000000300014. PubMed DOI

Disparate Roles of Oxidative Stress in Rostral Ventrolateral Medulla in Age-Dependent Susceptibility to Hypertension Induced by Systemic l-NAME Treatment in Rats